Q2 2024 |
25 |
$110M |
+$20.3M |
-$41.3M |
-$21M |
ADMA, ALIM, EOLS, GLPG, RVNC
|
Restatement |
8/20/2024, 08:59 PM |
Q1 2024 |
20 |
$126M |
+$30.1M |
-$172M |
-$142M |
EOLS, ADMA, ALIM, GLPG, RVNC
|
13F-HR |
5/14/2024, 06:12 PM |
Q4 2023 |
16 |
$231M |
+$2.28M |
-$91.8M |
-$89.5M |
EOLS, ADMA, AMLX, QDEL, ALIM
|
13F-HR |
2/13/2024, 04:25 PM |
Q3 2023 |
23 |
$301M |
+$76.2M |
-$20.2M |
+$56M |
QDEL, EOLS, AMLX, ADMA, GLPG
|
13F-HR |
11/13/2023, 04:02 PM |
Q2 2023 |
2 |
$11M |
$0 |
$0 |
|
XFOR, DCTH
|
New Holdings |
8/16/2023, 11:30 AM |
Q2 2023 |
21 |
$277M |
+$119M |
-$150M |
-$31.4M |
QDEL, EOLS, ADMA, GLPG, AMLX
|
13F-HR |
8/11/2023, 04:05 PM |
Q1 2023 |
22 |
$298M |
+$78.5M |
-$54.7M |
+$23.8M |
AMYT, GLPG, CTIC, ADMA, QDEL
|
13F-HR |
5/12/2023, 04:02 PM |
Q4 2022 |
19 |
$238M |
+$50.1M |
-$111M |
-$60.9M |
AMYT, APEN, CTIC, ADMA, QDEL
|
13F-HR |
2/14/2023, 12:46 PM |
Q3 2022 |
19 |
$222M |
+$46.6M |
-$27M |
+$19.6M |
AMYT, QDEL, CTIC, XERS, APEN
|
13F-HR |
11/10/2022, 05:05 PM |
Q2 2022 |
25 |
$215M |
+$61.7M |
-$51.2M |
+$10.5M |
AMYT, CTIC, XERS, ADMA, AMRN
|
13F-HR |
8/12/2022, 05:19 PM |
Q1 2022 |
28 |
$241M |
+$65.5M |
-$46.8M |
+$18.8M |
AMYT, CTIC, XERS, AMRN, OVID
|
13F-HR |
5/16/2022, 09:15 AM |
Q4 2021 |
23 |
$218M |
+$96M |
-$81.1M |
+$14.9M |
AMYT, CTIC, XERS, ADMA, OVID
|
13F-HR |
2/11/2022, 05:55 PM |
Q3 2021 |
31 |
$216M |
+$86M |
-$52.2M |
+$33.8M |
AMYT, CTIC, ADMS, GLPG, OVID
|
13F-HR |
11/12/2021, 04:41 PM |
Q2 2021 |
26 |
$191M |
+$45.5M |
-$36.2M |
+$9.33M |
AMYT, CHMA, CTIC, ADMS, CBIO
|
Restatement |
8/13/2021, 07:33 PM |
Q1 2021 |
29 |
$185M |
+$112M |
-$61.2M |
+$51M |
AMYT, ADMS, CHMA, CBIO, KALV
|
13F-HR |
5/14/2021, 04:18 PM |
Q4 2020 |
21 |
$131M |
+$38.2M |
-$31.2M |
+$6.99M |
LGND, AMYT, DMAC, AYTU, APEN
|
13F-HR |
2/12/2021, 05:11 PM |
Q3 2020 |
17 |
$96.1M |
+$47.9M |
-$5.11M |
+$42.8M |
LGND, ISEE, AMYT, CTIC, CBIO
|
13F-HR |
11/13/2020, 04:08 PM |
Q2 2020 |
13 |
$51.6M |
+$2.98M |
-$61.4M |
-$58.4M |
ISEE, LGND, CTIC, DMAC, CBIO
|
13F-HR |
8/13/2020, 04:24 PM |
Q1 2020 |
27 |
$94.6M |
+$43.3M |
-$24.8M |
+$18.5M |
LGND, ISEE, CTIC, AMRN, AFMD
|
13F-HR |
5/14/2020, 04:40 PM |
Q4 2019 |
23 |
$143M |
+$37.5M |
-$36M |
+$1.54M |
AMRN, ISEE, AFMD, OXFD, ADMS
|
13F-HR |
2/13/2020, 04:12 PM |
Q3 2019 |
26 |
$103M |
+$23.3M |
-$51.3M |
-$28M |
AMRN, OXFD, BDSI, ENTA, NEOS
|
13F-HR |
11/13/2019, 04:49 PM |
Q2 2019 |
25 |
$145M |
+$21.5M |
-$24.3M |
-$2.71M |
LGND, VNDA, AMRN, BDSI, ADMS
|
13F-HR |
8/13/2019, 04:42 PM |
Q1 2019 |
30 |
$174M |
+$78.5M |
-$40.9M |
+$37.6M |
VNDA, AMRN, LGND, NEOS, APEN
|
13F-HR |
5/14/2019, 04:24 PM |
Q4 2018 |
22 |
$114M |
+$23.4M |
-$43.5M |
-$20.1M |
AMRN, BDSI, BSTC, CPIX, APEN
|
13F-HR |
2/13/2019, 05:19 PM |
Q3 2018 |
31 |
$171M |
+$44.1M |
-$110M |
-$66.3M |
AMRN, APEN, BSTC, BDSI, CTIC
|
Restatement |
11/28/2018, 10:49 AM |
Q2 2018 |
25 |
$165M |
+$34.5M |
-$64.1M |
-$29.6M |
BSTC, CTIC, APEN, AMRN, VNDA
|
13F-HR |
8/13/2018, 07:01 PM |
Q1 2018 |
30 |
$187M |
+$66.7M |
-$43.8M |
+$22.9M |
BSTC, CTIC, AMRN, VNDA, APEN
|
13F-HR |
5/14/2018, 04:06 PM |
Q4 2017 |
27 |
$167M |
+$55.6M |
-$54.4M |
+$1.15M |
VIVE, BSTC, APEN, VNDA, ENTA
|
13F-HR |
2/13/2018, 04:52 PM |
Q3 2017 |
22 |
$170M |
+$44.4M |
-$63.4M |
-$19.1M |
VIVE, ENTA, PCRX, SCTL, NVLNF
|
13F-HR |
11/13/2017, 05:10 PM |
Q2 2017 |
27 |
$185M |
+$56.9M |
-$57.5M |
-$652K |
VIVE, ENTA, NVLNF, SCTL, VNDA
|
13F-HR |
8/14/2017, 11:44 AM |
Q1 2017 |
21 |
$177M |
+$32.7M |
-$32.9M |
-$185K |
SCTL, VIVE, NVLNF, SCLN, OPHT
|
13F-HR |
5/12/2017, 04:16 PM |
Q4 2016 |
23 |
$168M |
+$98.9M |
-$48M |
+$50.9M |
SCTL, ALR, SCLN, VIVE, NVLNF
|
13F-HR |
2/10/2017, 03:42 PM |
Q3 2016 |
17 |
$123M |
+$60M |
-$58.9M |
+$1.11M |
TBRA, VIVE, ALR, QLTI, SCTL
|
13F-HR |
11/14/2016, 12:08 PM |
Q2 2016 |
23 |
$97.5M |
+$43.7M |
-$41.3M |
+$2.33M |
SCLN, VNDA, TBRA, PTIE, QLTI
|
Restatement |
8/11/2016, 11:44 AM |
Q1 2016 |
19 |
$84.8M |
+$21M |
-$11.4M |
+$9.65M |
SCLN, VNDA, VCEL, PTIE, TBRA
|
13F-HR |
5/11/2016, 12:36 PM |
Q4 2015 |
13 |
$85.4M |
$0 |
$0 |
|
VNDA, CTIC, SCLN, TBRA, SGNT
|
13F-HR |
2/11/2016, 01:56 PM |